| scholarly article | Q13442814 |
| P50 | author | Anil K. Sood | Q88114757 |
| P2093 | author name string | Steven W Cole | |
| P2860 | cites work | Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP | Q22008544 |
| Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes | Q22008730 | ||
| Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines | Q28193194 | ||
| Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis | Q28348798 | ||
| Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors | Q33564373 | ||
| Computational identification of gene-social environment interaction at the human IL6 locus. | Q33778004 | ||
| Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis | Q33815723 | ||
| Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity | Q33895068 | ||
| Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues | Q33934262 | ||
| beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA | Q34092690 | ||
| Host factors and cancer progression: biobehavioral signaling pathways and interventions | Q34131970 | ||
| The sympathetic nervous system induces a metastatic switch in primary breast cancer | Q34134468 | ||
| Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis | Q34285076 | ||
| Do stress-related psychosocial factors contribute to cancer incidence and survival? | Q34592204 | ||
| Psychosocially influenced cancer: diverse early-life stress experiences and links to breast cancer | Q34680318 | ||
| Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling | Q34837191 | ||
| Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients | Q35012733 | ||
| Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer | Q35114450 | ||
| Stress hormone-mediated invasion of ovarian cancer cells | Q35120288 | ||
| Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. | Q35120653 | ||
| The influence of bio-behavioural factors on tumour biology: pathways and mechanisms | Q35135129 | ||
| Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival | Q35640094 | ||
| Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. | Q35877948 | ||
| β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study | Q36838466 | ||
| Depression, social support, and beta-adrenergic transcription control in human ovarian cancer | Q37180148 | ||
| Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition | Q37199666 | ||
| Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma | Q37276048 | ||
| Surgical stress promotes tumor growth in ovarian carcinoma. | Q37353385 | ||
| Catecholamines regulate tumor angiogenesis | Q37454112 | ||
| Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines | Q37455274 | ||
| Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action. | Q37856497 | ||
| Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs | Q38336991 | ||
| The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells | Q39726313 | ||
| Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor | Q39745162 | ||
| A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. | Q39905040 | ||
| Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer | Q40059218 | ||
| Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism | Q40089946 | ||
| Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation | Q40160207 | ||
| Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells | Q40213140 | ||
| Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma | Q40252227 | ||
| Transcriptional regulation by cyclic AMP. | Q41550266 | ||
| Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study | Q42483611 | ||
| Neonatal experiences differentially influence mammary gland morphology, estrogen receptor {α} protein levels, and carcinogenesis in BALB/c mice | Q42805776 | ||
| Rapid changes in the lymphopoietic and granulopoietic compartments of the marrow caused by stress levels of corticosterone | Q43889459 | ||
| Psychosocial stress augments tumor development through beta-adrenergic activation in mice | Q44083568 | ||
| Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells | Q44531462 | ||
| Beta blockers and breast cancer mortality: a population- based study | Q44536984 | ||
| Bone marrow norepinephrine mediates development of functionally different macrophages after thermal injury and sepsis | Q44949307 | ||
| Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. | Q46444989 | ||
| The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers | Q46870629 | ||
| Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication | Q46965728 | ||
| Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. | Q53903080 | ||
| Phagocyte-derived catecholamines enhance acute inflammatory injury | Q59082332 | ||
| Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma | Q59489502 | ||
| Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses | Q83809977 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1201-1206 | |
| P577 | publication date | 2011-12-20 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Molecular pathways: beta-adrenergic signaling in cancer | |
| P478 | volume | 18 |
| Q59809214 | 3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells |
| Q35829723 | A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer |
| Q48365559 | A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. |
| Q35077524 | A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response |
| Q28544627 | A network-based classification model for deriving novel drug-disease associations and assessing their molecular actions |
| Q27021528 | A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins |
| Q91517636 | Adaptive Transcriptional Responses by CRTC Coactivators in Cancer |
| Q44353447 | Adenosine promotes tumor metastasis |
| Q36226982 | Adrenergic DNA damage of embryonic pluripotent cells via β2 receptor signalling |
| Q50286895 | Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. |
| Q91892155 | Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation |
| Q89134834 | Adrenoceptor modulators and cancer progression |
| Q35627906 | Affective science perspectives on cancer control: strategically crafting a mutually beneficial research agenda |
| Q42702699 | Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer |
| Q38788459 | An on-chip model for investigating the interaction between neurons and cancer cells |
| Q57030114 | Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers |
| Q50981834 | Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells. |
| Q38115762 | Arterial hypertension and cancer. |
| Q92597215 | Association between Resting Heart Rate and Colorectal Cancer: Results from a Case-Controlled Study |
| Q40597334 | Association of Ovarian Tumor β2-Adrenergic Receptor Status with Ovarian Cancer Risk Factors and Survival |
| Q51158919 | Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population. |
| Q36169826 | Attractor landscape analysis of colorectal tumorigenesis and its reversion |
| Q52623821 | Autonomic nervous system and cancer. |
| Q36580367 | Behavioral stress accelerates prostate cancer development in mice |
| Q55428264 | Beneficial Effect of Fluoxetine and Sertraline on Chronic Stress-Induced Tumor Growth and Cell Dissemination in a Mouse Model of Lymphoma: Crucial Role of Antitumor Immunity. |
| Q47101799 | Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma |
| Q98778967 | Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression |
| Q64965191 | Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression. |
| Q90544208 | Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma |
| Q36385509 | Biobehavioral influences on recovery following hematopoietic stem cell transplantation |
| Q37654991 | Biomarker identification in breast cancer: Beta-adrenergic receptor signaling and pathways to therapeutic response |
| Q26745963 | Breast cancer and social environment: getting by with a little help from our friends |
| Q35067711 | Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation events |
| Q36153415 | Can propranalol prevent hepatocellular carcinoma? |
| Q55608083 | Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men. |
| Q64900773 | Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors. |
| Q38781876 | Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation |
| Q34391552 | Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice |
| Q38106901 | Central and peripheral nervous systems: master controllers in cancer metastasis |
| Q89725203 | Characterization of Drosophila octopamine receptor neuronal expression using MiMIC-converted Gal4 lines |
| Q90781394 | Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2 |
| Q89870061 | Classification of clear cell renal cell carcinoma based on PKM alternative splicing |
| Q55347068 | Clinical significance of expression levels of serum ADRA1A in hysterocarcinoma patients. |
| Q54122593 | Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway. |
| Q34654398 | Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines |
| Q35634097 | Diurnal cortisol and survival in epithelial ovarian cancer |
| Q97093353 | Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer |
| Q40458341 | Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice. |
| Q38769283 | Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study |
| Q38217219 | Effects on DNA Damage and/or Repair Processes as Biological Mechanisms Linking Psychological Stress to Cancer Risk |
| Q90209709 | Emotional distress, brain functioning, and biobehavioral processes in cancer patients: a neuroimaging review and future directions |
| Q36074296 | Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer |
| Q90179438 | Exercise as a Potential Intervention to Modulate Cancer Outcomes in Children and Adults? |
| Q37613495 | Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model |
| Q92837794 | Expression of beta adrenergic receptor in oral squamous cell carcinoma and its significance to the prognosis |
| Q35167040 | Expression of the beta-2 adrenergic receptor (ADRB-2) in human and monkey ovarian follicles: a marker of growing follicles? |
| Q47880195 | Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization. |
| Q36540471 | Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways |
| Q90221056 | Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β2 adrenergic receptor |
| Q38198618 | Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality |
| Q90317236 | High-fat diet feeding and palmitic acid increase CRC growth in β2AR-dependent manner |
| Q35754482 | Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation |
| Q96685944 | Impact of a natural disaster on access to care and biopsychosocial outcomes among Hispanic/Latino cancer survivors |
| Q38028205 | Impact of beta blockers on epithelial ovarian cancer survival |
| Q35586501 | Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients |
| Q36029972 | Impact of the Sensory Neurons on Melanoma Growth In Vivo |
| Q34089242 | Importance of adrenergic pathways in women's cancers |
| Q35067176 | In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins |
| Q38293740 | Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. |
| Q38716504 | Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells |
| Q36437049 | Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients |
| Q36738996 | Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism |
| Q38234527 | Mild cold-stress depresses immune responses: Implications for cancer models involving laboratory mice. |
| Q38131803 | Minding the body: psychotherapy and cancer survival |
| Q89622450 | Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression |
| Q37327436 | Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis |
| Q92890751 | Nerves in cancer |
| Q36692566 | Nervous system regulation of the cancer genome |
| Q26746714 | Neural regulation of cancer: from mechanobiology to inflammation |
| Q36306358 | Neuroendocrine influences on cancer progression. |
| Q27001639 | Neuroendocrine regulation of inflammation |
| Q37406486 | Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines |
| Q90288339 | Nonlinear heart rate variability biomarkers for gastric cancer severity: A pilot study |
| Q42434242 | Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression |
| Q89968808 | Norepinephrine-CREB1-miR-373 axis promotes progression of colon cancer |
| Q53950685 | Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets in silico and in vitro. |
| Q88003887 | Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic |
| Q37731479 | Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs |
| Q37056124 | Octopamine connects nutrient cues to lipid metabolism upon nutrient deprivation. |
| Q90033772 | Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients |
| Q46520435 | Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial. |
| Q57020351 | Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling |
| Q39236911 | Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts. |
| Q92891695 | Phenomenon of atypical vascular effects of epinephrine and an increase of photodynamic response by nitroglycerin in rats with colon adenocarcinoma: adrenergic and nitrergic mechanisms and novel applied aspects |
| Q92614323 | Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer |
| Q93130750 | Posttraumatic Stress Disorder Is Associated with Increased Risk of Ovarian Cancer: A Prospective and Retrospective Longitudinal Cohort Study |
| Q38859607 | Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study |
| Q33767409 | Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study |
| Q92708729 | Pre-diagnostic beta-blocker use and head- and neck cancer risk: A nationwide population-based case-control study |
| Q38793863 | Probing the response of human osteoblasts following exposure to sympathetic neuron-like PC-12 cells in a 3D coculture model |
| Q88726730 | Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS |
| Q47578456 | Propranolol Attenuates Surgical Stress-Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy |
| Q34489319 | Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression |
| Q95855170 | Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis |
| Q35858235 | Propranolol Reduces Cancer Risk: A Population-Based Cohort Study |
| Q37465305 | Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts |
| Q58761654 | Propranolol for the treatment of vascular sarcomas |
| Q99405224 | Propranolol induced apoptosis and autophagy via the ROS/JNK signaling pathway in Human Ovarian Cancer |
| Q37718449 | Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. |
| Q89575164 | Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial |
| Q49379372 | Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells. |
| Q92229502 | Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression |
| Q28116202 | Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation |
| Q27007708 | Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations |
| Q37266089 | Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways |
| Q36243213 | Putative Links Between Sleep Apnea and Cancer: From Hypotheses to Evolving Evidence |
| Q35089579 | Real-time detection of protein trafficking with high-throughput flow cytometry (HTFC) and fluorogen-activating protein (FAP) base biosensor |
| Q36884063 | Reciprocal regulation of PKA and Rac signaling |
| Q37593084 | Regulation of the Hippo pathway and implications for anticancer drug development |
| Q55303915 | Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. |
| Q53080898 | Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence. |
| Q48745127 | Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study. |
| Q38866740 | Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis |
| Q53574698 | Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors. |
| Q89873187 | Role of the nervous system in cancer metastasis |
| Q39914415 | Role of the nervous system in cancer metastasis. |
| Q36628603 | Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis |
| Q39019260 | Schwann cells: a new player in the tumor microenvironment |
| Q47673626 | Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review |
| Q47586118 | Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors. |
| Q37688636 | Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation |
| Q64938120 | Specific Urinary Metabolites in Malignant Melanoma. |
| Q57191793 | Stage-specific associations between beta blocker use and prognosis after colorectal cancer |
| Q92138562 | Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis |
| Q39177632 | Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. |
| Q99572232 | Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies |
| Q35755577 | Stress, metabolism and cancer: integrated pathways contributing to immune suppression |
| Q39110954 | Sympathectomized tumor-bearing mice survive longer but develop bigger melanomas. |
| Q64120859 | Sympathetic innervation contributes to perineural invasion of salivary adenoid cystic carcinoma via the β2-adrenergic receptor |
| Q38611988 | Sympathetic nerves: How do they affect angiogenesis, particularly during wound healing of soft tissues? |
| Q26795614 | Sympathetic nervous system regulation of the tumour microenvironment |
| Q37216993 | TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATION |
| Q58107297 | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
| Q92107881 | The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)? |
| Q90730152 | The Evaluation of Beta-2-Adrenoreceptors' Expression in Normal Peritumoral Tissue in Patients with Colorectal Adenocarcinoma |
| Q49592840 | The Impact of Housing Temperature-Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous System. |
| Q38783696 | The Role of Beta-Blockers in the Treatment of Hypertension |
| Q37389659 | The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure |
| Q38664877 | The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference |
| Q40499078 | The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells |
| Q38780472 | The potential roles of dopamine in malignant glioma |
| Q64884880 | The role of adrenergic receptors in lung cancer. |
| Q38244904 | The role of catecholamines in mesenchymal stem cell fate. |
| Q36500327 | The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms |
| Q38265246 | The trophoblast model of cancer |
| Q98725916 | The updated landscape of tumor microenvironment and drug repurposing |
| Q38246692 | The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action |
| Q96765710 | The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study |
| Q38662885 | Thermoneutrality, Mice, and Cancer: A Heated Opinion |
| Q97566222 | Tumor Excision as a Metastatic Russian Roulette: Perioperative Interventions to Improve Long-Term Survival of Cancer Patients |
| Q38054489 | Tumor dormancy and the neuroendocrine system: an undisclosed connection? |
| Q38333189 | Tumour-induced neoneurogenesis and perineural tumour growth: a mathematical approach |
| Q38625054 | Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population |
| Q44279417 | Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy |
| Q87388651 | [Interaction of anesthetics and analgesics with tumor cells] |
| Q37680065 | cAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells |
| Q38742275 | β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. |
| Q57295721 | β-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC |
| Q36213505 | β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells |
| Q41635699 | β-Adrenergic-stimulated macrophages: Comprehensive localization in the M1-M2 spectrum |
| Q44119515 | β-Blockers and metastasis in non-small-cell lung cancer |
| Q38619196 | β-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy. |
| Q38068208 | β-adrenergic-blocking drugs and melanoma: current state of the art. |
| Q36959073 | β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. |
| Q36443830 | β-blockers: a novel class of antitumor agents |
| Q90364630 | β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells |
| Q100533580 | β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism |
| Q38896403 | β2-AR signaling controls trastuzumab resistance-dependent pathway |
| Q89879738 | β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3 |
| Q36107924 | β3-adrenoreceptor and tumor microenvironment: a new hub. |
Search more.